These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7411382)

  • 21. A validational study of the WIST as a group-administered instrument for assessment of schizophrenic thinking.
    Klingler DE; Johnson JH; Williams TA
    J Clin Psychol; 1977 Jul; 33(3):658-61. PubMed ID: 893690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rating depression in schizophrenia. A comparison of a self-report and an observer report scale.
    Addington D; Addington J; Maticka-Tyndale E
    J Nerv Ment Dis; 1993 Sep; 181(9):561-5. PubMed ID: 8245924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anhedonia in schizophrenia].
    Loas G; Boyer P; Legrand A; Gayant C; Delahousse J
    Encephale; 1995; 21(6):453-7. PubMed ID: 8674470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rumination and negative symptoms in schizophrenia.
    Halari R; Premkumar P; Farquharson L; Fannon D; Kuipers E; Kumari V
    J Nerv Ment Dis; 2009 Sep; 197(9):703-6. PubMed ID: 19752652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlations between the MMPI and the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms in schizophrenic patients.
    Poreh AM; Chapin K; Rosen MD; Youssef I
    J Pers Assess; 1994 Oct; 63(2):275-83. PubMed ID: 7965572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thought disorder. A function of schizophrenia, mania, or psychosis?
    Marengo J; Harrow M
    J Nerv Ment Dis; 1985 Jan; 173(1):35-41. PubMed ID: 3965610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confusing thoughts and speech: source monitoring and psychosis.
    Henquet C; Krabbendam L; Dautzenberg J; Jolles J; Merckelbach H
    Psychiatry Res; 2005 Jan; 133(1):57-63. PubMed ID: 15698677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MMPI and Rorschach indices of schizophrenic and depressive diagnoses among adolescent inpatients.
    Archer RP; Gordon RA
    J Pers Assess; 1988; 52(2):276-87. PubMed ID: 3404390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability of Andreasen's thought, language and communications disorder scale.
    Davis GC; Simpson DM; Foster D; Arison Z; Post M
    Hillside J Clin Psychiatry; 1986; 8(1):25-33. PubMed ID: 3744296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MMPI measures as signs of predisposition to mental disorder among adoptees at high risk for schizophrenia.
    Siira V; Wahlberg KE; Miettunen J; Läksy K; Tienari P
    Psychiatry Res; 2008 Apr; 158(3):278-86. PubMed ID: 18272233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schizophrenic thinking and neuroleptic dosage.
    Puente AE; Andersson C
    J Clin Psychol; 1987 Mar; 43(2):189-97. PubMed ID: 2883201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thought disorder severity in compromised, deteriorated, and preserved intellectual course of schizophrenia.
    Mercado CL; Johannesen JK; Bell MD
    J Nerv Ment Dis; 2011 Feb; 199(2):111-6. PubMed ID: 21278540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MCMI-II diagnosis of schizophrenia: operating characteristics and profile analysis.
    del Rosario PM; McCann JT; Navarra JW
    J Pers Assess; 1994 Dec; 63(3):438-52. PubMed ID: 7844735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring schizophrenic thinking in older adolescents with the WAIS, Rorschach and WIST.
    Bilett JL; Jones NF; Whitaker LC
    J Clin Psychol; 1982 Apr; 38(2):232-43. PubMed ID: 7068856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring anxiety in patients with schizophrenia.
    Seedat S; Fritelli V; Oosthuizen P; Emsley RA; Stein DJ
    J Nerv Ment Dis; 2007 Apr; 195(4):320-4. PubMed ID: 17435482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thought disorder and schizophrenia: isolating and timing a mental event.
    Pishkin V; Lovallo W; Bourne LE
    J Clin Psychol; 1986 May; 42(3):417-24. PubMed ID: 2872234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for validity of the differential personality inventory.
    Kavanaugh PB; Auld F
    J Clin Psychol; 1977 Apr; 33(2):456-9. PubMed ID: 404322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primitive drive-dominated thinking: relationship to acute schizophrenia and sociopathy.
    Harrow M; Quinlan D; Wallington S; Pickett L
    J Pers Assess; 1976 Feb; 40(1):31-41. PubMed ID: 1255396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.